Skip to content

BIOX - Bioceres Crop Solutions Corp. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchB

Bioceres Crop Solutions Corp

BIOX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

B

BIOXBioceres Crop Solutions Corp

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.07
52-wk low: $0.30
Prev close: $1.64
Mkt cap: $26.5M
Fwd P/E: 15.0x
Beta: 0.46

Smart money

5 funds hold a position.

Real smart money

Funds holding this stock

5 holders

Combined position$345K

MW
Marshall Wace
Q1 2026 13F
$309K
position
P7
Point72
Steven Cohen · Q4 2025 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -96.9%
Forward P/E: 14.99
Market cap: $26M

Valuation

P/S0.10
P/B0.39

Quality

Operating margin-20.9%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: BIOX
Exchange: NASDAQ
Sector: BASIC MATERIALS
Industry: AGRICULTURAL INPUTS
Market cap: $26.46M
Beta: 0.46

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.1x

P/B

0.4x

Profit margin

-96.9%

Op margin

-20.9%

ROE

-32.2%

$18K

position

TS

Two Sigma

Q2 2026 13F

$11K

position

2 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 2 holders

Coverage gaps for BIOX

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Sep 8, 2026, in 18 days

Revenue expected

$0.00

0 analysts

ROE

-32.2%

ROA-0.9%

Growth

Beta0.46